Search Results - "Heit, J.A."

Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism by HEIT, J. A., CUNNINGHAM, J. M., PETTERSON, T. M., ARMASU, S. M., RIDER, D. N., DE ANDRADE, M.

“…Background: Venous thromboembolism (VTE) is highly heritable (estimated heritability [h2] = 0.62) and likely to be a result of multigenic action. Objective: To…”
Get full text

P-005: Venous thromboembolism risk in pregnant women with antithrombin deficiency by Marshall, A.L, Botero, J.P, Crusan, D.J, Petterson, T.M, Guenther, J.C, Chintakuntlawar, A.V, Pruthi, R.K, Ashrani, A.A, Heit, J.A, Patnaik, M.S

Get full text

P-004: Age-related risk of venous thromboembolism in women with antithrombin deficiency by Marshall, A.L, Perez Botero, J, Crusan, D.J, Petterson, T.M, Guenther, J.C, Chintakuntlawar, A.V, Pruthi, R.K, Ashrani, A.A, Heit, J.A, Patnaik, M.S

Get full text

Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism by Owen, B.A.L, Xue, A, Heit, J.A, Owen, W.G

“…Abstract The Calibrated Automated Thrombogram (CAT), a plate-based assay that measures thrombin generation and inhibition in plasma samples, is modified to…”
Get full text

Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study by Perez Botero, J, Ormsby, W.D, Ashrani, A.A, McBane, R.D, Wysokinski, W.E, Patnaik, M.M, Lewis, B.R, Grill, D.E, Pruthi, R.K, Heit, J.A

“…Abstract Introduction While Factor V Leiden ( F5 rs6025 A allele) is a known venous thromboembolism (VTE) risk factor, VTE risk among heterozygous vs…”
Get full text

A highly‐sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry by CHEN, D., DAIGH, C. A., HENDRICKSEN, J. I., PRUTHI, R. K., NICHOLS, W. L., HEIT, J. A., OWEN, W. G.

“…Background: Assays of plasma von Willebrand factor (VWF) ristocetin cofactor activity (VWF:RCo) are essential for the laboratory diagnosis of von Willebrand…”
Get full text

1344 – PDYN rs2281285 variant is associated with alcohol dependence in male but not female subjects by Karpyak, V.M, Winham, S.J, Preuss, U.W, Zill, P, Cunningham, J.M, Walker, D.L, Geske, J.R, Colby, C.L, Abulseoud, O.A, Hall-Flavin, D.K, Loukianova, L.L, Schneekloth, T.D, Frye, M.A, Bazov, I, Heit, J.A, Bakalkin, G, Mrazek, D.A, Biernacka, J.M

“…Introduction Recent findings support sex-specific effects of PDYN polymorphisms on association with opioid addiction (Clarke et al. 2012). We have demonstrated…”
Get full text

Abstract No. 24: Saphenous Vein Ablation Using Catheter-Directed Coil Embolization and Sclerotherapy by Barsoum, M.K, Bjarnason, H, Rooke, T.W, Cindy, F.L, Andrews, J.C, Petterson, T.M, Aslam, M, Heit, J.A

Get full text

Venous thromboembolism: disease burden, outcomes and risk factors by HEIT, J. A.

“…The epidemiology of venous thromboembolism (VTE) in the community has important implications for VTE prevention and management. This review describes the…”
Get full text

A genome‐wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q by HEIT, J. A., ARMASU, S. M., ASMANN, Y. W., CUNNINGHAM, J. M., MATSUMOTO, M. E., PETTERSON, T. M., DE ANDRADE, M.

“…Objectives:  To identify venous thromboembolism (VTE) disease‐susceptibility genes. Patients and methods:  We performed in silico genome wide association scan…”
Get full text

Predictors of major bleeding in peri‐procedural anticoagulation management by TAFUR, A. J., McBANE, R., WYSOKINSKI, W. E., LITIN, S., DANIELS, P., SLUSSER, J., HODGE, D., BECKMAN, M. G., HEIT, J. A.

“…Background: Appropriate periprocedural management for chronically anticoagulated patients requires assessment of patient‐specific thrombosis and bleeding…”
Get full text

The association of anti‐platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery by Welsby, I. J., Krakow, E. F., Heit, J. A., Williams, E. C., Arepally, G. M., Bar‐Yosef, S., Kong, D. F., Martinelli, S., Dhakal, I., Liu, W. W., Krischer, J., Ortel, T. L.

“…Essentials We evaluated antibody status, thromboembolism and survival after cardiac surgery. Positive antibody tests are common – over 50% are seropositive at…”
Get full text

Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study by Mauck, K. F., Froehling, D. A., Daniels, P. R., Dahm, D. L., Ashrani, A. A., Crusan, D. J., Petterson, T. M., Bailey, K. R., Heit, J. A.

“…Summary Background The incidence of symptomatic venous thromboembolism (VTE) after knee arthroscopy is uncertain. Objectives To estimate the incidence of…”
Get full text

Validation of an automated latex particle–enhanced immunoturbidimetric von Willebrand factor activity assay by CHEN, D., TANGE, J. I., MEYERS, B. J., PRUTHI, R. K., NICHOLS, W. L., HEIT, J. A.

“…Background: Laboratory diagnosis of von Willebrand disease (VWD) requires accurate measurement of plasma von Willebrand factor (VWF) activity. Objectives: To…”
Get full text

Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients by Tafur, A.J., Wysokinski, W.E., McBane, R.D., Wolny, E., Sutkowska, E., Litin, S.C., Daniels, P.R., Slusser, J.P., Hodge, D.O., Heit, J.A.

“…Patients with active cancer are often on chronic anticoagulation and frequently require interruption of this treatment for invasive procedures. The impact of…”
Get full text

Familial segregation of venous thromboembolism by Heit, J. A., Phelps, M. A., Ward, S. A., Slusser, J. P., Petterson, T. M., De Andrade, M.

“…Background: Venous thromboembolism (VTE) is postulated as a complex disease, but the heritability and mode of inheritance are uncertain. Objective: To…”
Get full text

The incidence of venous thromboembolism among Factor V Leiden carriers: a community‐based cohort study by HEIT, J. A., SOBELL, J. L., LI, H., SOMMER, S. S.

“…While Factor V (FV) Leiden is a risk factor for venous thromboembolism (VTE), the incidence of VTE among FV Leiden carriers is uncertain. The objective of the…”
Get full text

Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta‐analysis of eight studies by SMITH, N. L., HEIT, J. A., TANG, W., TEICHERT, M., CHASMAN, D. I., MORANGE, P.‐E.

Get full text

RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY by Heit, J.A., Marks, R.S., Ashrani, A.A., Petterson, T.M., Bailey, K.R., III, L.J. Melton

Get full text